Evidence map›Paper›PMID 37839881›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease.

Masaki Miyazawa, Masahiro Yanagi, Tomoyoshi Chiba, Hidenori Kido, Toshiki Matsuo, Masaki Nishitani, Noriaki Orita, Noboru Takata, Tomoyuki Hayashi, Akihiro Seki and 12 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Masaki MiyazawaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Masahiro YanagiDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Tomoyoshi ChibaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Hidenori KidoDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Toshiki MatsuoDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Masaki NishitaniDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Noriaki OritaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Noboru TakataDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Tomoyuki HayashiDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Akihiro SekiDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Hidetoshi NakagawaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Kouki NioDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Takeshi TerashimaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Noriho IidaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Shinya YamadaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Hajime TakatoriDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Tetsuro ShimakamiDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Kuniaki AraiDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Tatsuya YamashitaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Eishiro MizukoshiDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Masao HondaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Taro YamashitaDepartment of Gastroenterology, Kanazawa University Hospital, Japan.
Kanazawa University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a rare case of idiopathic portal hypertension (IPH)-like disease that developed after allogeneic hematopoietic stem cell transplantation (allo-HSCT). A 53-year-old woman who underwent allo-HSCT for acute myeloid leukemia showed portal hypertension with radiological and histopathological findings consistent with IPH, distinct from veno-occlusive disease (VOD) and graft-versus-host disease (GVHD) of the liver. This case highlights the importance of considering IPH-like disease as a potential cause of portal hypertension after allo-HSCT. Awareness of this complication can aid in the early diagnosis and appropriate management of patients post allo-HSCT.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseHypertension, PortalFemaleHumansLeukemia, Myeloid, AcuteLiver CirrhosisMiddle AgedTransplantation, Homologousallogeneic hematopoietic stem cell transplantationesophageal varicesgraft-versus-host diseaseidiopathic portal hypertensionveno-occlusive disease

Identifiers

PMID37839881
PMCPMC11189707
OpenAlexW4387566960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.